- Home
- GCTS vs NVCT Comparison
GCTS vs NVCT Comparison
Compare GCTS & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- NVCT
- Stock Information
- Founded
- GCTS 1998
- NVCT 2020
- Country
- GCTS United States
- NVCT United States
- Employees
- GCTS N/A
- NVCT N/A
- Industry
- GCTS Blank Checks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- GCTS Finance
- NVCT Health Care
- Exchange
- GCTS Nasdaq
- NVCT Nasdaq
- Market Cap
- GCTS 109.3M
- NVCT 119.4M
- IPO Year
- GCTS N/A
- NVCT 2022
- Fundamental
- Price
- GCTS $2.23
- NVCT $4.90
- Analyst Decision
- GCTS Strong Buy
- NVCT Strong Buy
- Analyst Count
- GCTS 1
- NVCT 1
- Target Price
- GCTS $8.00
- NVCT $21.00
- AVG Volume (30 Days)
- GCTS 163.6K
- NVCT 303.6K
- Earning Date
- GCTS 11-14-2024
- NVCT 11-05-2024
- Dividend Yield
- GCTS N/A
- NVCT N/A
- EPS Growth
- GCTS N/A
- NVCT N/A
- EPS
- GCTS N/A
- NVCT N/A
- Revenue
- GCTS $11,532,000.00
- NVCT N/A
- Revenue This Year
- GCTS N/A
- NVCT N/A
- Revenue Next Year
- GCTS $571.35
- NVCT N/A
- P/E Ratio
- GCTS N/A
- NVCT N/A
- Revenue Growth
- GCTS N/A
- NVCT N/A
- 52 Week Low
- GCTS $2.12
- NVCT $4.69
- 52 Week High
- GCTS $56.00
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- GCTS 39.08
- NVCT 35.71
- Support Level
- GCTS $2.12
- NVCT $4.75
- Resistance Level
- GCTS $2.43
- NVCT $5.49
- Average True Range (ATR)
- GCTS 0.19
- NVCT 1.14
- MACD
- GCTS -0.04
- NVCT -0.52
- Stochastic Oscillator
- GCTS 14.19
- NVCT 3.02
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.